Skip to main content

The Immunology of Pneumococcal Pneumonia

  • Chapter
Pulmonary Infections and Immunity

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

Abstract

Streptococcus pneumoniae is a leading cause of community acquired pneumonia, sinusitis, otitis media, and meningitis. The organism was first independently isolated by Pasteur and by Sternberg in 1880, and its association with lobar pneumonia was uncovered just a few years later.1 There are an estimated 150,000–570,000 cases of pneumococcal pneumonia in the United States each year and an estimated annual attack rate of 68–260 cases per 100,000 population.2 Closed communities may experience higher attack rates. The male to female ratio is 3:2. The highest age-specific incidence of infection is seen in infants younger than 2 years of age, but, in adults, the risk of infection increases with advancing age.3 Despite the availability of effective therapy, pneumonia caused by this organism remains potentially life-threatening with an overall case fatality rate of 5–7%. Both underlying disease, and youth or old age contribute significantly to higher mortality rates, and in some patient groups (e.g., alcoholics), the case fatality rate may be as high as 25%.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Austrian R., 1960, The Gram stain and the etiology of pneumonia: An historical note, Bacteriol. Rev. 24:261–265.

    PubMed  CAS  Google Scholar 

  2. 1984, Pneumococcal polysaccharide vaccine, Morb. Mortal. Wkly. Rep. 33:273–276, 281.

    Google Scholar 

  3. Burnman, L. A., Norrby, R., and Trollfors, B., 1985, Invasive pneumococcal infections: Incidence, predisposing factors, and prognosis, Rev. Infect. Dis. 7(2): 133–142.

    Article  Google Scholar 

  4. Austrian, R., 1986, Some aspects of the pneumococcal carrier state, J. Antimicrob. Chemother. 18(Suppl A):35–45.

    Article  PubMed  Google Scholar 

  5. Gray, B. M. and Dillon, H. C., Jr., 1989, Natural history of pneumococcal infections, Pediatr. Infect. Dis. J. 8(Suppl 1):S23–S25.

    Article  Google Scholar 

  6. Gray, B. M., Converse, G. M., III, and Dillon, H. C., Jr., 1980, Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life, J. Infect. Dis. 142:923–933.

    Article  PubMed  CAS  Google Scholar 

  7. Boulnois, G. J., 1992, Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae, J. Gen. Microbiol. 138:249–259.

    Article  CAS  Google Scholar 

  8. Bruyn, G. A. W., Zegers, B. J. M., and van Furth, R., 1992, Mechanisms of host defense against infection with Streptococcus pneumoniae, Clin. Infect. Dis. 14:251–262.

    Article  CAS  Google Scholar 

  9. Austrian, R., 1980, Pneumococci. in: Microbiology, Third Edition, (B. D. Davis, R. Dulbecco, H. N. Eisen, and H. S. Ginsberg, eds.) Harper and Row, Philadelphia, pp. 596–606.

    Google Scholar 

  10. Johnston, R. B., Jr., 1991, Pathogenesis of pneumococcal pneumonia, Rev. Infect. Dis. 13(Suppl 6):S509–S517.

    Article  Google Scholar 

  11. Mufson, M. A., 1981, Pneumococcal infections, JAMA 246:1942–1948.

    Article  PubMed  CAS  Google Scholar 

  12. Ginsburg, I., 1981, Streptococcus, in: Medical Microbiology and Infectious Diseases, (A. L. Braude, C. E. Davis, and J. Fierer, eds.) W. B. Saunders, Philadelphia, pp. 281–295.

    Google Scholar 

  13. Lee, C. J., Koizumi, K., Henrichsen, J., Perch, B., Lin, C. S., and Egan, W., 1984, Capsular polysaccharides of nongroupable streptococci that cross-react with pneumococcal group 19, J. Immunol. 133(5):2706–2711.

    PubMed  CAS  Google Scholar 

  14. Fischer, H. and Tomasz, A., 1985, Peptidoglycan crosslinking and teichoic acid attachment in Streptococcus pneumoniae, J. Bacteriol. 163:46–54.

    CAS  Google Scholar 

  15. Leon, M. A. and Young, N. M., 1971, Specificity for phosphorylcholine of six murine myeloma proteins reactive with pneumococcus C polysaccharide and beta-lipoprotein, Biochemistry 10:1424–1429.

    Article  PubMed  CAS  Google Scholar 

  16. Tomasz, A., 1981, Surface components of Streptococcus pneumoniae, Rev. Infect. Dis. 3: 190–211.

    Article  CAS  Google Scholar 

  17. Musher, D. M., Watson, D. A., and Baughn, R. E., 1990, Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J. Infect. Dis. 161:736–740.

    Article  PubMed  CAS  Google Scholar 

  18. Chen Szu, S., Schneerson, R., and Robbins, J. B., 1986, Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae to fail to protect mice from lethal challenge with encapsulated pneumococci, Infect. Immun. 54(2):448–455.

    Google Scholar 

  19. Riesenfeld-Orn, I., Wolpe, S., Garcia-Bustos, J. F., Hoffmann, M. K., and Tuomanen, E., 1989, Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components, Infect. Immun. 57:189–193.

    Google Scholar 

  20. Gotschlich, E. C. and Liu, T. Y., 1967, Structural and immunological studies on the pneumococcal C polysaccharide, J. Biol. Chem. 242:463–470.

    PubMed  CAS  Google Scholar 

  21. Riesenfeld-Orn, I., Tuomanen, E., Tomasz, A., Hengstler, B., and Zal, O., 1985, The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis, J. Infect. Dis. 151:535–540.

    Article  Google Scholar 

  22. Tuomanen, E., Liu, H., Hengstler, B., Zak, O., and Tomasz, A., 1985, The induction of meningeal inflammation by components of the pneumococcal cell wall, J. Infect. Dis. 151:859–868.

    Article  PubMed  CAS  Google Scholar 

  23. Tuomanen, E., Rich, R., and Zak, O., 1987, Induction of pulmonary inflammation by components of the pneumococcal cell surface, Am. Rev. Respir. Dis. 135:869–874.

    PubMed  CAS  Google Scholar 

  24. Cabellos, C., Maclntyre, D. E., Forrest, M., Burroughs, M., Prasad, S., and Tuomanen, E., 1992, Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae, J. Clin. Invest. 90: 612–618.

    Article  CAS  Google Scholar 

  25. Kohayakawa, M. and Issoue, K., 1986, Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein, Thromb. Res. 41:649–657.

    Article  PubMed  CAS  Google Scholar 

  26. Geelen, S., Bhattacharya, C., and Tuomanen, E., 1992, Induction of procoagulant activity on human endothelial cells by Streptococcus pneumoniae, Infect. Immun. 60:4179–4183.

    CAS  Google Scholar 

  27. Berry, A. M., Lock, R. A., Hansman, D., and Paton, J. C., 1989, Contribution of autolysin to virulence of Streptococcus pneumoniae, Infect. Immun. 57:2037–2042.

    CAS  Google Scholar 

  28. Lock, R. A., Hansman, D., and Paton, J. C., 1992, Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae, Microbial Pathogen. 12:137–143.

    Article  CAS  Google Scholar 

  29. Watson, D. A. and Musher, D. M., Interruption of capsule production in S. pneumoniae serotype 3 by insertion of transposon Tn916, Infect. Immun. 58:3135–3138.

    Google Scholar 

  30. Ansfield, M. J., Woods, D. E., and Johanson, W. G., Jr., 1977, Lung bacterial clearance in murine pneumococcal pneumonia, Infect. Immun. 17:195–204.

    PubMed  CAS  Google Scholar 

  31. Esposito, A. L. and Clark, C. A., 1990, The effects of capsular polysaccharide on the capacity of serum to support the killing of type 3 Streptococcus pneumoniae by human neutrophils, Apmis 98:812–822.

    Article  PubMed  CAS  Google Scholar 

  32. Lee, C. J., Banks, S. D., and Li, J. P., 1991, Virulence, immunity, and vaccine related to Streptococcus pneumoniaeCrit. Rev. Microbiol. 18:89–114.

    Article  PubMed  CAS  Google Scholar 

  33. Knecht, J. C., Schiffman, G., and Austrian, R., 1970, Some biological properties of pneumococcus type 37 and the chemistry of its capsular polysaccharide, J. Exp. Med. 132:475–487.

    Article  PubMed  CAS  Google Scholar 

  34. Heffron, R., 1979, in: Pneumonia, with special reference to pneumococcus lobar pneumonia, Harvard University Press, Cambridge, Massachusetts.

    Google Scholar 

  35. Fine, D. P., 1975, Pneumococcal type-associated variability in alternate complement pathway activation, Infect. Immun. 12:772–778.

    PubMed  CAS  Google Scholar 

  36. Giebink, G. S., Verhoef, J., Peterson, P. K., and Quie, P. G., 1977, Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV, Infect. Immun. 18:291–297.

    PubMed  CAS  Google Scholar 

  37. Boulnois, G. J., Paton, J. C., Mitchell, T. J., and Andrew, P. W., 1991, Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae, Mol. Microbiol. 5(11):2611–2616.

    Article  PubMed  CAS  Google Scholar 

  38. Walker, J. A., Allen, R. L., Flamagne, P., Johnson, M. K., and Boulnois, G. J., 1987, Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae, Infect. Immun. 55(5):1184–1189.

    CAS  Google Scholar 

  39. Korchev, Y. E., Bashford, C. L., and Pasternak, C. A., 1992, Differential sensitivity of pneumolysin-induced channels to gating by divalent cations, J. Membrane Biol. 127: 195–203.

    Article  CAS  Google Scholar 

  40. Saunders, F. K., Michell, T. J., Walker, J. A., Andrew, P. W., and Boulnois, G. J., 1989, Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity, Infect. Immun. 57:2547–2552.

    PubMed  CAS  Google Scholar 

  41. Nandoskar, M., Ferrante, A., Bates, E. J., Hurst, N., and Paton, J., 1986, Inhibition of monocyte respiratory burst, degradation, phospholipid methylation and bactericidal activity by pneumolysin, Immunology 59:515–520.

    PubMed  CAS  Google Scholar 

  42. Paton, J. C. and Ferrante, A., 1983, Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity and migration by pneumolysin, Infect. Immun. 41:1212–1216.

    PubMed  CAS  Google Scholar 

  43. Feldman, C., Mitchell, T. J., Andrew, P. W., Boulnois, G. J., Read, R. C., Todd, H., Cole, P. J., and Wilson, R., 1990, The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro, Microbial Pathogen. 9:275–284.

    Article  CAS  Google Scholar 

  44. Feldman, C., Read, R., Rutman, A., Jeffery, P. K., Brain, A., Lund, V., Mitchell, T. J., Andrew, P. W., Boulnois, G. J., Todd, H. C., et al., 1992, The interaction of Streptococcus pneumoniae with intact human respiratory mucosa in vitro Eur. Respir. J. 5(5):576–583.

    PubMed  CAS  Google Scholar 

  45. Rubins, F. B., Duane, P. G., Charboneau, D., and Janoff, E. N., 1992, Toxicity of pneumolysin to pulmonary endothelial cells in vitro, Infect. Immun. 60(5): 1740–1746.

    PubMed  CAS  Google Scholar 

  46. Feldman, C., Munro, N. C., Jeffrey, P. K., Mitchell, T. J., Andrew, P. W., Boulnois, G. J., Guerreiro, D., Rohde, J. A., Todd, H. C., Cole, P. J., et al., 1991, Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lungin vivo, Am. J. Respir. Cell. Mol. Biol 5:416–423.

    Article  PubMed  CAS  Google Scholar 

  47. Lock, R. A., Paton, J. C., and Hansman, D., 1988, Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae, Microbial Pathogen. 5:461–467.

    Article  CAS  Google Scholar 

  48. Rubins, J. B., Duane, P. G., Charboneau, D., and Janoff, E. N., 1992, Toxicity of pneumolysin to pulmonary endothelial cells in vitro, Infect. Immun. 60:1740–1746.

    PubMed  CAS  Google Scholar 

  49. Coonrod, J. D., Varble, R., and Yoneda, K., 1991, Mechanism of killing of pneumococci by lysozyme, J. Infect. Dis. 164:527–532.

    Article  PubMed  CAS  Google Scholar 

  50. Andersson, B., Beachey, E. H., Tomasz, A., Tuomanen, E., and Svanborg-Eden, C., 1988, A sandwich adhesin on Streptococcus pneumoniae attaching to human oropharyngeal epithelial cells in vitro, Microbial Pathogen 4:267–278.

    Article  CAS  Google Scholar 

  51. Kurono, Y., Shimamura, K., Shigami, H., and Mogi, G., 1991, Inhibition of bacterial adherence by nasopharyngeal secretions, Ann. Otol. Rhinol. Laryngol 100:455–458.

    PubMed  CAS  Google Scholar 

  52. Kilian, M., Mestecky, J., Kulhavy, R., Tomana, M., and Butler, W. T., 1980, IgAt proteases from Hemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: Comparative immunochemical studies, J. Immunol. 124:2596–2600.

    PubMed  CAS  Google Scholar 

  53. Kilian, M. J., Mestecky, J., and Schrohenloher, R. E., 1979, Pathogenic species of the genus Hemophilus and Streptococcus pneumoniae produce IgA1 protease, Infect. Immun. 26:143–149.

    PubMed  CAS  Google Scholar 

  54. Male, C. J., 1979, Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoniae, Infect. Immun. 26:254–261.

    PubMed  CAS  Google Scholar 

  55. Kilian, M. and Reinhold, J., 1986, Interference with IgA defense mechanisms by extracellular bacteria enzymes, Med. Microbiol. 5:173–208.

    CAS  Google Scholar 

  56. Winkelstein, J. A. and Swift, A. J., 1975, Host defense against the pneumococcus in T-lymphocyte deficient, nude mice, Infect. Immun. 12:1222–1223.

    PubMed  CAS  Google Scholar 

  57. Szu, S. C., Clarke, S., and Robbins, J. B., 1983, Protection against pneumococcal infection in mice conferred by phosphocholine-binding and relation to several types, Infect. Immun. 39:993–999.

    PubMed  CAS  Google Scholar 

  58. Talkington, D. F., Crimmins, D. L., Voellinger, D. C., Yother, J., and Briles, D. E., 1991, A 43-kilodalton pneumococcal surface protein, PspA: Isolation, protective abilities, and structural analysis of the amino-terminal sequence, Infect. Immun. 59:1285–1289.

    PubMed  CAS  Google Scholar 

  59. Au, C. C. and Eisenstein, T. K., 1981, Evaluation of the pneumococcal Forssman antigen (F-polysaccharide) in the cross-serotype protection induced by pneumococcal subcellular preparations, Infect. Immun. 31:169–173.

    PubMed  CAS  Google Scholar 

  60. Griffoen, A. W., Rykers, G. T., Toebes, E. A. H., and Egers, B. J. M., The human in vitro anti-type 4 pneumococcal polysaccharide antibody response is regulated by suppressor T cells, Scand. J. Immunol. 34:229–234.

    Google Scholar 

  61. Tvede, N., Heilmann, C., and Christensen, L. D., 1989, Interleukin 2 receptor expression by human blood lymphocytes after vaccination with pneumococcal polysaccharides, Clin. Exp. Immunol. 76:404–411.

    PubMed  CAS  Google Scholar 

  62. Winkelstein, J. A., 1984, Complement and the host’s defense against the pneumococcus, Crit. Rev. Microbiol. 11(3): 187–208.

    Article  PubMed  CAS  Google Scholar 

  63. Guckian, J. C., Christensen, G. D., and Fine, D. P., 1980, The role of opsonins in recovery from experimental pneumococcal pneumonia, J. Infect. Dis. 142:175–190.

    Article  PubMed  CAS  Google Scholar 

  64. Coonrod, J. D. and Rylkp-Bauer, B., 1977, Complement-fixing antibody response in pneumococcal pneumonia, Infect. Immun. 18:617–623.

    PubMed  CAS  Google Scholar 

  65. Mold, C., Nakayama, S., Holzer, T. J., Gewurz, H., and DuClos, T. W., 1981, C-reactive protein is protective against Streptococcus pneumoniae infection in mice, J. Exp. Med. 154:1703–1708.

    Article  PubMed  CAS  Google Scholar 

  66. Kaplan, M. H. and Volnakis, J. E., 1974, Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin, J. Immunol. 112:2135–2147.

    PubMed  CAS  Google Scholar 

  67. Osmond, A. P., Mortensen, R. F., Siegel, J., and Gewurz, H., 1975, Interactions of C-reactive protein with the complement system. III. Complement-dependent passive hemolysis initiated by CRP, J. Exp. Med. 142:1065–1077.

    Article  Google Scholar 

  68. Ziegler-Heitbrock, H. W. L., Passlick, B., Kafferlein, E., Coulie, P. G., and Izbicki, J. R., 1992, Protection against lethal pneumococcal septicemia in pigs is associated with decreased levels of interleukin-6 in blood, Infect. Immun. 60:1692–1694.

    PubMed  CAS  Google Scholar 

  69. Mitchell, T. J., Andrew, P. W., Saunders, F. K., Smith, A. N., and Boulnois, G. J., 1991, Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein, Mol. Microbiol. 5(8): 1883–1888.

    Article  PubMed  CAS  Google Scholar 

  70. Winkelstein, J. A., Shin, H. S., and Wood, W. B., Jr., 1972, Heat labile opsonins to pneumococcus. III. The participation of immunoglobulin and of the alterative pathway of C3 activation, J. Immunol. 108:1681–1689.

    PubMed  CAS  Google Scholar 

  71. Brown, E. J., Joiner, K. A., Gaither, T. A., Hammer, C. A., and Frank, M. M., 1983, The interaction of C3b bound to pneumococci with factor H (β-1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system, J. Immunol. 131:409–415.

    PubMed  CAS  Google Scholar 

  72. Winkelstein, J. A. and Tomasz, A., 1978, Activation of the alternative pathway by pneumococcal cell wall teichoic acid, J. Immunol. 120:174–178.

    PubMed  CAS  Google Scholar 

  73. Winkelstein, J. A., Bocchini, J. A., Jr., and Schiffman, G., 1976, The role of the capsular polysaccharide in the activation of the alterative pathway by the pneumococcus, J. Immunol. 116:367–370.

    PubMed  CAS  Google Scholar 

  74. Hand, W. I. and Cantey, J. R., 1974, Antibacterial mechanisms of the lower respiratory tract. I. Immunoglobulin synthesis and secretion, J. Clin. Invest. 53:354–362.

    Article  PubMed  CAS  Google Scholar 

  75. Robertson, J., Caldwell, J. R., Castle, J. R., and Waldman, R. H., 1976, Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions, J. Immunol. 117:900–903.

    PubMed  CAS  Google Scholar 

  76. Reynolds, H. Y. and Newball, H. H., 1974, Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage, J. Lab. Clin. Med. 84:559–573.

    PubMed  CAS  Google Scholar 

  77. Stephens, C. G., Williams, R. C., Jr., and Reed, W. P., 1977, Classical and alternative complement pathway activation by pneumococci, Infect. Immun. 17:296–302.

    PubMed  CAS  Google Scholar 

  78. Holzer, T. J., Edwards, K. M., Gewurz, H., and Mold, C., 1984, Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis, J. Immunol. 133:1424–1430.

    PubMed  CAS  Google Scholar 

  79. Hosea, S. W., Brown, E. J., and Frank, M. M., 1980, The critical role of complement in experimental pneumococcal sepsis, J. Infect. Dis. 142:903–909.

    Article  PubMed  CAS  Google Scholar 

  80. Wood, W. B., Jr., 1941, Studies on the mechanism of recovery in pneumococcal pneumonia. I. The action of specific antibody upon the type of pulmonary lesion of experimental pneumonia, J. Exp. Med. 73:201–222.

    Article  PubMed  CAS  Google Scholar 

  81. Nakajima, R., Namba, K., Ishida, Y., Une, T., and Osada, Y., 1990, Protective role of complement in the development of experimental pneumococcal pneumonia in mice, Chemotherapy 36:287–293.

    Article  PubMed  CAS  Google Scholar 

  82. Johnston, R. B., Jr., 1981, The host response to invasion by Streptococcus pneumoniae: Protection and the pathogenesis of tissue damage, Rev. Infect. Dis. 3:282–288.

    Article  PubMed  Google Scholar 

  83. Osler, W., 1978, Lobar Pneumonia, in: The Principles and Practice of Medicine: Designed For the Use of Practitioners and Students of Medicine (A. M. Harvey and V. A. McKusick, eds.), New York: Appleton-Century-Crofts, pp. 75–107.

    Google Scholar 

  84. Newman, S. L., Vogler, L. B., Feigin, R. D., and Johnston, R. B., Jr., 1979, Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway, N. Engl. J. Med. 299:290–292.

    Article  Google Scholar 

  85. Sjoholm, A. G., Hallberg, T., Oxelius, V. A., Hammarstrom, L., Smith, C. I. E., and Lindgren, F., 1987, C2 deficiency, moderately low IgG2 concentrations and lack of G2m(23) allotype marker in a child with repeated bacterial infections, Acta. Paediatr. Scand. 76: 533–588.

    Article  PubMed  CAS  Google Scholar 

  86. Rosen, F. S. and Janeway, C. A., 1966, The gamma globulins. III. The antibody deficiency syndromes, N. Engl. J. Med. 275:709–715.

    Article  PubMed  CAS  Google Scholar 

  87. Matter, L., Wilhelm, J. A., Angehrn, W., Skvaril, F., and Schopfer, K., 1985, Selective antibody deficiency and recurrent pneumococcal bacteremia in a patient with Sjogren’s syndrome, hyperimmunoglobulinemia G, and deficiencies of IgG2 and IgG4, N. Engl. J. Med. 1039–1042.

    Google Scholar 

  88. Twomey, J. J., 1973, Infections complicating multiple myeloma and chronic lymphocytic leukemia, Arch. Intern. Med. 132:562–565.

    Article  PubMed  CAS  Google Scholar 

  89. Rimland, D., 1983, Mechanisms of ethanol-induced defects of alveolar macrophage function, Alcoholism 8:73–76.

    Google Scholar 

  90. Astry, C. L., Warr, G. A., and Jakab, G. J., 1983, Impairment of PMN immigration as a mechanism of alcohol-induced suppression of pulmonary antibacterial defenses, Am. Rev. Respir. Dis. 128:113–117.

    PubMed  CAS  Google Scholar 

  91. Okeson, G. C., and Divertie, M. B., 1970, Cilia and bronchial clearance: The effects of pharmacologic agents and disease, Mayo Clin. Proc. 45:361–373.

    PubMed  CAS  Google Scholar 

  92. Spinozzi, F., Cimignoli, E., Gerli, R., Agea, E., Bertotto, A., Rondoni, F., and Grignani, F., 1992, IgG subclass deficiency and sinopulmonary bacterial infections in patients with alcoholic liver disease, Arch. Intern. Med. 152:99–104.

    Article  PubMed  CAS  Google Scholar 

  93. Perlino, C. A. and Rimland, D., 1985, Alcoholism, leukopenia, and pneumococcal sepsis, Am. Rev. Respir. Dis. 132:757–760.

    PubMed  CAS  Google Scholar 

  94. Liu, Y. K., 1980, Effects of alcohol on granulocytes and lymphocytes, Sem. Hematol. 17: 13–136.

    Google Scholar 

  95. Imperia, P. S., Chikkapa, G., and Phillips, P. G., 1984, Mechanism of inhibition of granulopoiesis by ethanol, Proc. Soc. Exp. Biol. Med. 174:219–225.

    Article  Google Scholar 

  96. Davis, C. C., Mellencamp, M. A., and Preheim, L. C., 1991, A model of pneumococcal pneumonia in chronically intoxicated rats, J. Infect. Dis. 163:799–805.

    Article  PubMed  CAS  Google Scholar 

  97. Lister, P. D., Preheim, L. C., and Gentry, M. J., 1992, Ethanol impairs neutrophil Chemotaxis but not adherence or recruitment to lungs in rats with experimental pneumococcal pneumonia, Abstracts of the 92nd General Meeting of the American Society for Microbiology, abstract B-235:65.

    Google Scholar 

  98. MacGregor, R. R., Gluckman, S. J., and Senior, J. R., 1978, Granulocyte function and levels of immunoglobulins and complement in patients admitted for withdrawal from alcohol, J. Infect. Dis. 138:747–753.

    Article  PubMed  CAS  Google Scholar 

  99. Perrin, L. H., Lambert, P. H., Nydegger, U. E., and Miescher, P. A., 1973, Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level, Clin. Immunol. Immunopathol. 2:16–27.

    Article  PubMed  CAS  Google Scholar 

  100. MacGregor, R. R., 1986, Alcohol and immune defense, JAMA 256:1474–1479.

    Article  PubMed  CAS  Google Scholar 

  101. Zetterman, R. K. and Sorrell, M. F., 1981, Immunologic aspects of liver disease, Gastroenterology 81:616–624.

    PubMed  CAS  Google Scholar 

  102. Mellencamp, M. A. and Preheim, L. C., 1991, Pneumococcal pneumonia in a rat model of cirrhosis: Effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae, J. Infect. Dis. 163:102–108.

    Article  CAS  Google Scholar 

  103. Rimola, A., Soto, R., Bory, F., Arroyo, V., Piera, C., and Rodes, J., 1984, Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis, Hepatology 4:53–58.

    Article  PubMed  CAS  Google Scholar 

  104. Grover, G. J. and Loegering, D. J., 1984, Role of the liver in host defense to pneumococcus following splenectomy, J. Surg. Res. 37:448–452.

    Article  PubMed  CAS  Google Scholar 

  105. Plotkowski, M. C., Puchelle, E., Beck, G., Jacquot, J., and Hannoun, C., 1986, Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus, Am. Rev. Respir. Dis. 134:1040–1044.

    PubMed  CAS  Google Scholar 

  106. Tristram, D. A., Miller, R. W., McMillan, J. A., and Weiner, L. B., 1988, Simultaneous infection with respiratory syncytial virus and other respiratory pathogens, Am. J. Dis. Child. 142:834–836.

    PubMed  CAS  Google Scholar 

  107. Korppi, M., Leinonen, M., Koskela, M., Makela, H., and Launiala, K., 1989, Bacterial coinfection in children hospitalized with respiratory syncytial virus infections, Pediatr. Dis. J. 8:687–692.

    Article  CAS  Google Scholar 

  108. Jones, E. E., Alford, P. L., Reingold, A. L., Russell, H., Keeling, M. E., and Broome, C. V, 1984, Predisposition to invasive pneumococcal illness following parainfluenzae type 3 virus infection in chimpanzees, J. Am. Vet. Med. Ass. 185:1351–1353.

    CAS  Google Scholar 

  109. O’Neal, B. J., and McDonald, J. C., 1981, The risk of sepsis in the asplenic adult, Ann. Surg. 194:775–778.

    Article  PubMed  Google Scholar 

  110. Schwartz, P. E., Sterioff, S., Mucha, P., Melton, L. J., and Offord, K. P., 1982, Postsplenec-tomy sepsis and mortality in adults, JAMA 248:2279–2283.

    Article  PubMed  CAS  Google Scholar 

  111. Selby, C., Hart, S., Ispahani, P., and Toghill, P. J., 1987, Bacteremia in adults after splenectomy or splenic irradiation, Quarterly J. Med. 63:523–530.

    CAS  Google Scholar 

  112. Herbert, J. C., 1989, Pulmonary antipneumococcal defenses after hemisplenectomy, J. Trauma 29:1217–1220.

    Article  Google Scholar 

  113. Zarkowsky, H. S., Gallagher, D., Gill, F. M., Wang, F. C., Falletta, J. M., Lande, W. M., Levy, P. S., Verter, J. I., Wethers, D., and the Cooperative Study of Sickle Cell Disease, 1986, Bacteremia in sickle hemoglobinopathies, J. Pediatr. 109:579–585.

    Article  PubMed  CAS  Google Scholar 

  114. Pearson, H. A., Spencer, R. P., and Cornelius, F. A., 1969, Functional asplenia in young children with sickle-cell anemia, N. Engl. J. Med. 281:923–926.

    Article  PubMed  CAS  Google Scholar 

  115. Bjornson, A. B., Lobel, J. S., and Harr, K. S., 1985, Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle-cell disease, J. Infect. Dis. 152:701–708.

    Article  PubMed  CAS  Google Scholar 

  116. Van Wyck, D. B., Witte, M. H., and Witte, C. L., 1982, Synergism between the spleen and serum complement in experimental pneumococcemia, J. Infect. Dis. 145:514–519.

    Article  PubMed  Google Scholar 

  117. Redd, S. C., Rutherford, G. W., III, Sande, M., Lifson, A. R., Hadley, W. K., Facklam, R. R., and Spika, J. S., 1990, The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents, J. Infect. Dis. 162:1012–1017.

    Article  PubMed  CAS  Google Scholar 

  118. Pesola, G. R. and Charles, A., 1992, Pneumococcal bacteremia with pneumonia; Mortality in acquired immunodeficiency syndrome, Chest 101:150–155.

    Article  PubMed  CAS  Google Scholar 

  119. Pahwa, S. G., Quilop, M. T. J., Lange, M., Pahwa, R. N., and Grieco, M. H., 1984, Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome, Ann. Intern. Med. 101:757–763.

    Article  PubMed  CAS  Google Scholar 

  120. Lane, H. C., Masur, H., Edgar, L. C., Whalen, G., Rook, A. H., and Fauci, A. S., 1983, Abnormalities of B cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome, N. Engl. J. Med. 309:453–458.

    Article  PubMed  CAS  Google Scholar 

  121. Pinching, A. J., 1991, Antibody responses in HIV infection, Clin. Exp. Immunol. 84: 181–184.

    PubMed  CAS  Google Scholar 

  122. Parkin, J. M., Helbert, M., Hughes, C. L., and Pinching, A. J., 1989, Immunoglobulin G subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS, AIDS 3:37–39.

    PubMed  CAS  Google Scholar 

  123. Glaser, J. B., Volpe, S., Aguirre, A., Simpkins, H., and Schiffman, G., 1991, Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex, J. Infect. Dis. 164:761–764.

    Article  PubMed  CAS  Google Scholar 

  124. Senaldi, G., Peakman, M., McManus, T., Davies, E. T., Tee, D. E. H., and Vergani, D., 1990, Activation of the complement system in human immunodeficiency virus infection: Relevance of the classical pathway to pathogenesis and disease severity, J. Infect. Dis. 162:1227–1232.

    Article  PubMed  CAS  Google Scholar 

  125. Chou, M. Y., Brown, A., Blevins, A., and Armstrong, D., 1983, Severe pneumococcal infection in patients with neoplastic disease, Cancer 51:1546–1550.

    Article  PubMed  CAS  Google Scholar 

  126. Zurlo, J. J., Schechter, G. P., and Fries, L. F., 1989, Complement abnormalities in multiple myeloma, Am. J. Med. 87:411–420.

    Article  PubMed  CAS  Google Scholar 

  127. Savage, D. G., Lindenbaum, J., and Garrett, T. J., 1982, Biphasic pattern of bacterial infection in multiple myeloma, Ann. Intern. Med. 96:47–50.

    Article  PubMed  CAS  Google Scholar 

  128. Simons, R. J. and Reynolds, H. Y., 1990, Altered immune status in the elderly, Sem. Respir. Dis. 5:251–259.

    CAS  Google Scholar 

  129. Esposito, A. L., Poirier, W. J., and Clark, C. A., 1989, The cardiac glycoside digoxin disrupts host defense in experimental pneumococcal pneumonia by impairing neutrophil mobilization, Am. Rev. Respir. Dis. 140:1590–1594.

    Article  PubMed  CAS  Google Scholar 

  130. Amber, I. J., Gilbert, E. M., Schiffman, G., and Jacobson, J. A., 1990, Increased risk of pneumococcal infections in cardiac transplant recipients, Transplantation 49:122–125.

    Article  PubMed  CAS  Google Scholar 

  131. McLean, R. H., Forsgren, A., Bjorksten, B., Kim, Y., Quie, P. G., and Michael, A. F., 1977, Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome, Pediatr. Res. 11:910–916.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kemper, C.A., Deresinski, S.C. (1994). The Immunology of Pneumococcal Pneumonia. In: Chmel, H., Bendinelli, M., Friedman, H. (eds) Pulmonary Infections and Immunity. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1063-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1063-9_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1065-3

  • Online ISBN: 978-1-4899-1063-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics